Allen Kuan-Liang Chen
Overview
Explore the profile of Allen Kuan-Liang Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
350
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sriram S, Kang N, Subramanian S, Nandi T, Sudhagar S, Xing Q, et al.
Stem Cell Res Ther
. 2021 Feb;
12(1):113.
PMID: 33546754
Background: Despite recent rapid progress in method development and biological understanding of induced pluripotent stem (iPS) cells, there has been a relative shortage of tools that monitor the early reprogramming...
2.
Sivalingam J, Chen H, Yang B, Lim Z, Lam A, Woo T, et al.
Haematologica
. 2018 Mar;
103(7):e279-e283.
PMID: 29519863
No abstract available.
3.
Lee E, Lim Z, Chen H, Yang B, Lam A, Chen A, et al.
Biotechnol J
. 2018 Jan;
13(4):e1700567.
PMID: 29330927
Anticipated shortages in donated blood supply have prompted investigation of alternative approaches for in vitro production of red blood cells (RBCs), such as expansion of conditional immortalization erythroid progenitors. However,...
4.
Yap L, Murali S, Bhakta G, Titmarsh D, Chen A, Sim L, et al.
J Biomed Mater Res B Appl Biomater
. 2017 Sep;
106(5):1887-1896.
PMID: 28941021
Functionalizing medical devices with polypeptides to enhance their performance has become important for improved clinical success. The extracellular matrix (ECM) adhesion protein vitronectin (VN) is an effective coating, although the...
5.
Lam A, Li J, Toh J, Sim E, Chen A, Chan J, et al.
Cytotherapy
. 2016 Dec;
19(3):419-432.
PMID: 28017598
Large numbers of human mesenchymal stromal cells (MSCs) used for a variety of applications in tissue engineering and cell therapy can be generated by scalable expansion in a bioreactor using...
6.
Sivalingam J, Lam A, Chen H, Yang B, Chen A, Reuveny S, et al.
Tissue Eng Part C Methods
. 2016 Jul;
22(8):765-80.
PMID: 27392822
In vitro generation of red blood cells (RBCs) from human embryonic stem cells and human induced pluripotent stem cells appears to be a promising alternate approach to circumvent shortages in...
7.
Lam A, Chen A, Ting S, Reuveny S, Oh S
Biochem Biophys Res Commun
. 2015 Sep;
473(3):764-8.
PMID: 26385176
Current methods for human pluripotent stem cells (hPSC) expansion and differentiation can be limited in scalability and costly (due to their labor intensive nature). This can limit their use in...
8.
Lam A, Li J, Chen A, Birch W, Reuveny S, Oh S
Biores Open Access
. 2015 Aug;
4(1):242-57.
PMID: 26309800
Human pluripotent stem cells (hPSC) are self-renewing cells having the potential of differentiation into the three lineages of somatic cells and thus can be medically used in diverse cellular therapies....
9.
Chen A, Chew Y, Tan H, Reuveny S, Oh S
Cytotherapy
. 2014 Oct;
17(2):163-73.
PMID: 25304664
Background Aims: Large amounts of human mesenchymal stromal cells (MSCs) are needed for clinical cellular therapy. In a previous publication, we described a microcarrier-based process for expansion of MSCs. The...
10.
Lam A, Chen A, Li J, Birch W, Reuveny S, Oh S
Stem Cell Res Ther
. 2014 Sep;
5(5):110.
PMID: 25223792
Introduction: Myocardial infarction is accompanied by a significant loss of cardiomyocytes (CMs). Functional CMs, differentiated from human embryonic stem cells (hESCs), offer a potentially unlimited cell source for cardiac disease...